Arrowhead Pharmaceuticals, Inc. ( NASDAQ: ARWR) Q1 2025 Earnings Conference Call February 10, 2025 4:30 PM ET Chris Anzalone - President & CEO Bruce Given - Interim Chief Medical Scientist Andy Davis ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2025 first quarter ended December 31, 2024. The Company is hosting a conference call today, February 10, ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ: SRPT) announced on November 26, 2024, has now ...

AM Oriental Trimex Ltd.(up 2.80%) were among the top gainers. Ashapura Minechem Ltd.(down 3.50%), KIOCL Ltd.(down 3.01%), Pokarna Ltd.(down 2.90%), NMDC Ltd.(down 2.74%), MOIL Ltd.(down 2.72%), The ...

Absa has been recognised as a Top Employer for 2025 by the prestigious Top Employer Institute (TEI), marking the fourth consecutive year it has received this accolade. The certification spans six key ...

The embattled ex-speaker of the Lagos State House of Assembly, Mudashiru Obasa, is plotting to remove the incumbent Speaker, ...

Around 8. 48am, Fayemi presented prizes to outstanding trainees. It took him 12 minutes to complete the exercise. He was up ...

Arrowhead Pharmaceuticals recently received the FDA NDA acceptance for Plozasiran. Read why I believe ARWR stock could be a ...

Arrowhead (ARWR) announced that the global licensing and collaboration agreement with Sarepta Therapeutics (SRPT) announced on November 26, ...

Here are the seven top business stories you need to track this week — February 10 to February 15 TINUBU asks n'assembly to ...